Anti-SARS-CoV-2 monoclonal antibody therapy is effective at preventing severe disease in stem cell transplant and cellular immunotherapy recipients diagnosed with sars-cov-2

Ajayi, E.; Baluch, A.; Klinkova, O.; Nishihori, T.; Pasikhova, Y.; Quilitz, R.; Marco, D.; Elmariah, H.; Locke, F.; McIver, B.; Mishra, A.; Jain, M.; Anasetti, C.; Nieder, M.; Bejanyan, N.; Pidala, J.; Alsina, M.; Perez, L.; Lazaryan, A.; Liu, H.; Ochoa, L.; Khimani, F.; Hansen, D.; Castanedapuglianini, O.; Freeman, C.; Faramand, R.

Ajayi, E.; Baluch, A.; Klinkova, O.; Nishihori, T.; Pasikhova, Y.; Quilitz, R.; Marco, D.; Elmariah, H.; Locke, F.; McIver, B.; Mishra, A.; Jain, M.; Anasetti, C.; Nieder, M.; Bejanyan, N.; Pidala, J.; Alsina, M.; Perez, L.; Lazaryan, A.; Liu, H.; Ochoa, L.; Khimani, F.; Hansen, D.; Castanedapuglianini, O.; Freeman, C.; Faramand, R..

Bone Marrow Transplantation ; 57(SUPPL 1):259-260, 2022.

Article in English | Web of Science | ID: covidwho-2112229

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: Bone Marrow Transplantation Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML